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Abstract
Anionic vesicles containing acidic phospholipids are known complement activators. To clarify which negative physicochemical electrostatic
charges on vesicles and structural specificities of acidic lipids are critical to complement activation, the electrostatic properties and activity
to complement of two anionic vesicles modified with a carboxylic acid derivative or a conventional acidic phospholipid were compared.
Electrophoretic mobility measurements indicated that the negative zeta potential and the electrostatic interactivity of these two anionic vesicles
were equal at pH 7.4. However, the infusion of vesicles containing acidic phospholipid induced significant complement activation, while vesicles
containing the carboxylic acid derivative failed to activate complement. These results indicate that the negative charge on the surface of vesicles is
not critical for the activation complement, suggesting that complement activation is specific to the structure of acidic groups. This finding is likely
to be important to the design of anionic biointerfaces and may support the promising medical applications of this anionic vesicle modified with a
carboxylic acid derivative.
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Anionic vesicles (liposomes), commonly formulated by mi-
xing acidic phospholipids such as phosphoglycerol, phospho-
serin, phosphoinositol, phosphatidic acid, cardiolipin, and poly
(ethylene glycol) (PEG) conjugated phosphoethanolamine in
lipid components are known to mediate complement activation
[1–5]. Complement activation, which is followed by systemic
immune activation and anaphylaxis shock, is regarded as a criti-
cal problem in the clinical setting of various biomaterials. The
C1q subcomponent of C1 has a highly cationic region in residues
14–26 of the C1qA polypeptide chain, and this specific region of
the collagenous stalk of C1q has been identified as being involved
in interactions with negatively charged activators [5–8]. It is⁎ Corresponding author. Tel.: +81 3 5286 3120; fax: +81 3 3205 4740.
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doi:10.1016/j.bbamem.2008.01.006believed that the antibody-independent binding of C1q to the
negatively charged surface of vesicles initiates the activation of
the complement cascade via the classical complement pathway
[2]. To prevent complement activation, the acidic phospholipids
can be removed or their negative charge can be protected by
chemical modification [2,4]. It has also been reported that surface
modification with a dense PEG layer is effective for preventing
complement activation by covering the surface charge [9].
Our group has developed phospholipid vesicles called he-
moglobin-vesicles that encapsulate human hemoglobin and
that can be used as a substitute for red blood cells and as an
alternative to conventional transfusion [10–14]. To achieve this
challenging application of vesicles, we had to develop anionic
vesicles capable of encapsulating hemoglobin using a minimum
amount of lipids, retaining the negative charge on the membrane
which reduces the lamellarity of vesicles and is required for
improving encapsulation capacity [11–13]. Several acidic lipids
have been tested and a carboxylic acid derivative, L-glutamic
Fig. 1. Structure of acidic lipids for surface modification of vesicles. (A) Chemical
structure of L-glutamic acid, N-(3-carboxy-1-oxopropyl)-, 1,5-dihexadecyl ester
(SA) and 1,2-dipalmitoyl-sn-glycero-3-phosphoglycerol (PG). The focus of this
study is the different acidic groups shown in the dotted circle. (B) The CPK model
of SA and PG with 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (PC) to estimate
the distance of acidic groups from the membrane surface of PC. CPKmodels show
the structure with minimized energy in molecular mechanistic calculation.
1036 K. Sou, E. Tsuchida / Biochimica et Biophysica Acta 1778 (2008) 1035–1041acid, N-(3-carboxy-1-oxopropyl)-, 1,5-dihexadecyl ester (SA),
has been used as an anionic component. Vesicles containing SA
have been demonstrated to efficiently encapsulated hemoglobin,
and given their stability, can be infused in considerably large
doses as a red blood cell substitute [15,16]. In addition, admi-
nistration of this formulation is not associated with considera-
ble rejection by the blood immune system and complement in
animals [17,18]. Recent collaboration involving our group found
that vesicles containing SA are selectively captured by bone
marrow macrophages at small injection doses in rabbits [19].
This targeting of bone marrow has not yet been reported for
conventional anionic vesicles. These findings suggest that the
surface characteristics of the anionic vesicles have a marked
effect on their associated biological events and that this is highly
dependent upon the nature of the acidic groups.
Based on the hypothesis that the negative electrostatic charge
of acidic phospholipids on the surface of vesicles is one of
the factors responsible for inducing complement activation, the
electrostatics of vesicles containing SA may differ from those
of vesicles containing acidic phospholipids. Conversely, when
the electrostatic interactivity of these acidic lipids is equal,
biological events such as complement activation are likely to
be mediated by the molecular specificity of acidic lipids. To
elucidate what aspects are critical to the biocompatibility and
performance of anionic vesicles, a comparative analysis of the
electrostatic interfacial properties of vesicles containing either
SA or acidic phospholipids is essential. In this study, we elu-
cidated the electrostatic interfacial properties of vesicles con-
taining SA or an acidic phospholipid by electrophoretic mobility
measurement and observed complement activation after the
infusion of these vesicles in animals. The results clearly de-
monstrated that the negatively charged group on the surface of
anionic vesicles is not critical to the activation of complement.
2. Materials and methods
2.1. Materials
1,2-Dipalmitoyl-sn-glycero-3-phosphocholine (PC), cholesterol (CH), and
1,2-dipalmitoyl-sn-glycero-3-phosphoglycerol (PG), and L-glutamic acid, N-(3-
carboxy-1-oxopropyl)-, 1,5-dihexadecyl ester (SA), were purchased from Nippon
Fine Chemical Co. Ltd. (Osaka, Japan). 1,2-Distearoyl-sn-glycero-3-phosphoetha-
nolamine-N-[monomethoxy poly(ethylene glycol) (5000)] (PEG-DSPE) was
purchased from NOF Co. (Tokyo, Japan). Pentalysine and poly-L-lysine (Mw.
15–30 kDa) were purchased from SIGMA (St. Louis, MO).
2.2. Preparation of vesicles
Vesicle samples were produced using PC and CH (1:1, molar ratio, PC-
vesicles), and varying amounts of SA (SA-vesicles) or PG (PG-vesicles). The
mixed lipids were added to 10 mM phosphate buffer (NaCl; 20 mM, pH 7.4) and
the dispersion was introduced into an extruder (Lipex Biomembrane, Canada)
and extruded through the membrane filters (final pore size: 0.2 μm, Isopore®,
Millipore, Tokyo, Japan) under pressure using nitrogen gas. For animal ex-
periments, vesicleswere composed of PC, CH, and SAor PG (1:1:0.2, molar ratio),
with 0.3 mol% of PEG-DSPE incorporated to prevent the aggregation of vesicles
[20]. Samples for animal experiments were prepared under sterile conditions.
2.3. Characterization of vesicles
The diameters of the resulting vesicles were determined with a COULTER
submicron particle analyzer (N4SD, Coulter, Hialeah, FL), and the averagediameter±standard deviation (SD) was calculated. The phospholipid concentra-
tion was determined using a cholineoxidase method (Phospholipid C Test Wako;
Wako Pure Chem., Tokyo). Endotoxin contamination in the samples prepared
for the animal experiment was determined to be less than 0.1 EU/mL by the
Limulus assay test [21].
2.4. Determination of zeta potential
A 10 μL aliquot of vesicles (lipid concentration: 2 g/dL) was diluted in 2 mL
of 10 mM phosphate buffer (pH 3–9, 37 °C) containing 20 mM NaCl and
incubated for 1 h at 37 °C. The pH was determined using a pH meter with a
pH electrode (F-52, HORIBA, Kyoto, Japan) at 37 °C and the electrophoretic
mobility of vesicles (lipid concentration: 0.01 g/dL) were determined by Laser
Doppler Velocimetry (Zeta-Sizer Nano ZS, Malvern Instruments, Malvern,
Worcestershire, UK). Measurement conditions and parameters were as follows:
37 °C, dielectric constant 74.4 (for dilute water solution), viscosity 0.6864 cP
(for dilute water solution), and the applied voltage was 20 V/cm. The zeta
potential was determined by measuring the electrophoretic mobility (UE), and
the zeta potential (ζ) and applied to the Henry equation:
UE ¼ 2eff jRð Þ3g ð1Þ
where ɛ is the dielectric constant, η is the viscosity of the solvent, f(κR) is the
Henry function, κ is the Debye–Hückel parameter and the R is the radius of
the particle. The Smoluchowski equation was used with f(κR)=1.5 employed in
the zeta potential calculations. Measurements were performed four times for
each sample and statistical analysis was conducted using the average±SD of the
four measurements.
Fig. 2. Zeta potential of vesicles modified with SA (SA-vesicles) and PG
(PG-vesicles) as a function of acidic lipid content. Zeta potentials were measured
in 10 mM phosphate buffer (pH 7.4, NaCl; 20 mM) at 37 °C.
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The electrostatic interactivity of the anionic vesicles was evaluated using the
change in the zeta potential in presence of Ca2+, pentalysine, and poly-L-lysine
(Mw. 15–30 kDa) as an index. A 10 μL aliquot of vesicles (lipid concentration:
2 g/dL) was diluted in 2 mL of 10 mM 2-[4-(2-Hydroxyethyl)-1-piperazinyl]
ethanesulfonic acid (HEPES) buffer (pH 7.4, 37 °C) containing 0–3 mM CaCl2
and 17–20 mM NaCl (total 20 mM), or containing varying amounts of pen-
talysine or poly-L-lysine (Mw. 15–30 kDa) with 20 mM NaCl. The dispersions
were incubated for 1 h at 37 °C before mobility measurement of the vesicles was
performed by electrophoresis as described in Section 2.4.
2.6. Animal experiments
Animal experiments were conducted under the guidelines recommended by
the National Institutes of Health, Animal Use and Care and the protocol was
approved by the Steering Committee for Animal Experimentation at Waseda
University. Male Wistar rats (250±20 g) were anesthetized with ether. The
vesicular dispersion (5 g/dL) was introduced into rats through the tail veins
at 1 mL/min (n=5 for each sample). Each rat received 5.6 mL/kg of body
weight of vesicle dispersion (lipids: 280 mg/kg of body weight). At 1 or 24 h
after injection, the blood was collected and centrifuged to separate the serum
(1×103 g, 10 min). The collected serum was further ultracentrifuged to remove
the vesicles (3×105 g, 30 min). The 50% hemolytic unit of complement serum
(CH50) was determined in accordance with general procedures for clinical
laboratory tests by a commercial company (BML, Japan).
2.7. Statistical methods
The data from the animal experiments are reported as means±standard
error of the mean. Statistical analysis was performed using Microsoft Excel for
Windows and CH50 values were compared using Student's unpaired t test.3. Results and discussion
3.1. Samples
Two characteristic acidic lipids used in this study are shown
in Fig. 1. SA and PG each have carboxylic acid and phosphoric
acid as ionized groups, respectively. Both lipids have a strongly
hydrophobic dialkyl structure to fix the ionized groups on ve-
sicle surface. The molecular length indicated by the CPK model
showed that the carboxylate anion of SA and the phosphate
anion of PG would be located at the surface of PC-vesicles
(Fig. 1B). Various amounts of SA and PGwere incorporated into
the PC/CH membrane (1:1, molar ratio) of the anionic vesicles.
The size of vesicles was controlled by extrusion methods (final
pore size: 0.2 μm), with final mean diameters of approximately
200 nm (Table 1). The vesicles prepared without acidic lipidsTable 1
Diameter of prepared vesicles containing various amounts of acidic lipid
Acidic lipid
(mol%)
Mean diameter±SD (nm)
SA-vesicles PG-vesicles
0 (PC-vesicles) 232±60 232±60
1 224±58 230±60
5 193±50 196±58
9 205±40 204±49
15 194±45 199±55
20 198±52 194±64or with 1 mol% of acidic lipids tended to be slightly larger
(ca 30 nm) than vesicles containing more acidic lipids. This
effect of acidic lipids on the size of vesicles could be due to the
improved dispersion stability of vesicles and electrostatic re-
pulsion of the anionic surfaces. The vesicles without acidic
lipids were observed to precipitate in a day, indicating poor
dispersion stability. Vesicles without acidic lipids containing
small amount of PEG-DSPE to prevent aggregation had
diameters of 202±49 nm. Therefore, the slightly large diameter
of vesicles without acidic lipids or with 1 mol% of acidic lipids
may be the cause for their increased aggregability. The low
aggregability of vesicles having large zeta potential is due to
their electrostatic repulsive interaction causing anionic vesicles
to exist as stable dispersions.
3.2. Zeta potential of vesicles
The zeta potential is the electrostatic potential at the hydro-
dynamic slip plane, and is characterized as having an electrical
double-layer consisting of the Stern layer and the diffuse layer.
Fig. 2 shows the zeta potential of prepared vesicles as a func-
tion of acidic lipid content at pH 7.4. Vesicles containing PC/CH
(1:1, molar ratio) have an almost neutral surface (zeta potential:
−2.22±0.62 mV), indicating that the surface is inactive for elec-
trostatic events. The magnitude of the negative charge on the
surface increased with the incorporation of SA or PG, indicating
that the ionized groups of SA and PG act to characterize the vesicle
surface depending on their content. The zeta potentials of SA-
vesicles and PG-vesicles reached −54.2±3.68 mV and −49.0±
2.89 mV for acidic lipids of 20 mol%, respectively, with the
negative zeta potential of SA-vesicles being relatively higher
compared to that of PG-vesicles at any concentration. In theory,
the electrostatic potential is dependent upon distance from the
membrane surface as well as surface charge density [22]. The
slightly extended negative charge of SA from the surface shown
in Fig. 1B, would reduce the distance between the change to slip
plane, resulting in the higher negative zeta potential of SA-vesicles.
Fig. 4. Change in zeta potential of vesicles as a function of Ca2+ concentration.
Vesicles were dispersed at 100 μg/mL in 10 mM HEPES buffer (pH 7.4, at
37 °C) containing NaCl and CaCl2 (total: 20 mM). PC-vesicles: PC/ CH (1:1,
molar ratio), SA-vesicles: PC/CH/SA (1:1:0.2, molar ratio), and PG-vesicles:
PC/CH/PG (1:1:0.2, molar ratio).
Fig. 3. Ionization state of acidic groups as a function of pH. (A) Zeta potential of
vesicles (PC/CH, 1:1, molar ratio) (PC-vesicles), and vesicles containing 9 mol%
ofSA (SA-vesicles) or PG (PG-vesicles) at various pH.Zeta potentialsweremeasured
in 10 mM phosphate buffer (NaCl; 20 mM) at various pH (37 °C). (B) Schematic
representation of the ionization state of acidic groups with pH. The apparent pKas of
SA-vesicles and PG-vesicles were calculated to be 5.4 and b3.
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component of vesicles is equal to acidic phospholipids at pH 7.4.
3.3. Ionization properties of acidic lipids
Stability of the ionization state conferred by acidity is an
important characteristic of acidic compounds. We examined the
ionization properties of acidic lipids as a function of pH using
SA-vesicles and PG-vesicles containing acidic lipids of 9 mol%
with zeta potentials of −40.7±2.09 mV and −35.4±0.61 mV
(at pH 7.4), respectively. As shown in Fig. 3A, the zeta po-
tential of SA-vesicles varied markedly depending on the en-
vironmental pH (pH 3–7). The change in the zeta potential of
SA-vesicles is thought to reflect the ionization state of SA, as
control vesicles without SA, namely PC-vesicles, maintained
almost neutral surfaces irrespective of pH. The relationship
between pH and the pKa of the acid is expressed using the well-
known Henderson–Hasselbalch equation as follows:
pH ¼ pKa þ log COO
½ 
COOH½  : ð2Þ
When we analyzed the data shown in Fig. 3A using Eq. (2)
and the assumption that the zeta potential was linearly correlated
with the ionization acid, the pKa of the carboxyl group of SA
was estimated as 5.4 (Fig. 3B). Above pH 7, the zeta potential of
SA-vesicles was almost constant, indicating that the carboxylgroup of SA would mostly be ionized above pH 7. The zeta
potentials of PG-vesicles were almost constant in the range
pH 4–9, indicating that the ionized form of the phosphoric
acid moiety is stable in this range. The change in the zeta
potential observed at a pH lower than pH 4, and its pKa would
be lower than pH 3 [23,24]. Thus, we confirmed that the surface
of SA-vesicles and PG-vesicles exhibited the characteristics of
a weak acid with SA and a strong acid with PG, respectively,
indicating that the individual characteristics of acidic groups
are expressed on the surface of vesicles. We also observed
that the magnitude of the negative electrostatic charges in SA-
vesicles was equal to that observed in PG-vesicles at appro-
ximately neutral pH.
3.4. Electrostatic interactivity
Ca2+ is found in biological fluids (normally 2–3 mM in
plasma) and is known to mediate biological processes by
binding to the anionic domains such as those involved in
the specific binding of proteins to membranes [25,26]. Aci-
dic phospholipids, such as PG and PS, are also known to bind
Ca2+ [27–29]. As shown in Fig. 4, the negative charge on
anionic vesicles was suppressed by increasing the concentra-
tion of Ca2+. When the concentration of Ca2+ was increased to
3 mM, the zeta potentials of SA-vesicles and PG-vesicles were
−16.4±1.9 mV and −13.8±1.4 mV, respectively. Recently,
Hautala et al. reported that vesicles containing phosphatidic
acid possess a specifically strong affinity for Ca2+, and that the
zeta potential of these vesicles changed from being strongly
negative to positive after binding Ca2+ [29]. These authors also
showed that other acidic phospholipids, including PG, do not
exhibit a strong affinity towards becoming cationic. Conse-
quently, one aim of this experiment was to determine whether
the binding of Ca2+ is a specificity factor between SA-vesi-
cles and PG-vesicles, and also whether the surface of SA-
vesicles remained negative in the presence of Ca2+. Our
experiment showed that the surface of the SA-vesicles remained
Fig. 6. Change in zeta potential of vesicles as a function of the concentration of
basic macromolecule (poly-L-lysine, Mw. 15–30 kDa). Vesicles were dispersed
at 100 μg/mL in 10 mM HEPES buffer (pH 7.4, at 37 °C, NaCl, 20 mM)
containing various amount of poly-L-lysine. PC-vesicles: PC/CH (1:1, molar ratio),
SA-vesicles: PC/CH/SA (1:1:0.2, molar ratio), and PG-vesicles: PC/CH/PG
(1:1:0.2, molar ratio).
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SA-vesicles and PG-vesicles also showed that the specificity
of binding Ca2+ was not observed.
Additional model-based studies of electrostatic interacti-
vity, pentalysine and poly-L-lysine (Mw. 15–30 kDa with a
repeating primary lysine amine) were also conducted. Oligo-
mers or polymers of lysine are often used to model basic
peptides or macromolecules and their electrostatic interactions
on membranes [30,31]. As shown in Fig. 5, the zeta potential
is a linear function of the concentration of pentalysine. The
lines, which represent the least-squares best fit, have slopes of
9.3 and 7.4 mV per decade for the pentalysine concentrations
in SA-vesicles and PG-vesicles. The slope for PC-vesicles was
as little as 0.26 mV per decade of pentalysine concentration
(data not shown), indicating that the negative charge of aci-
dic lipids mediate the interaction with basic pentalysine. A
change in the zeta potential is due to binding of basic pep-
tide [31] and a similar decay slope of the zeta potential would
indicate that the binding constant of a basic peptide to SA-
vesicles and PG-vesicles was similar. As shown in Fig. 6,
the change in the zeta potential of these vesicles due to the
interaction with poly-L-lysine increased drastically, changing
from a negative to a positive in presence of 1.5–2 μg/mL poly-
L-lysine. Conversely, the change in the surface potential of PC-
vesicles was negligible, indicating that the acidic lipids mediate
the interaction with basic macromolecules. This experiment
also demonstrates that the interactivity of SA-vesicles and PG-
vesicles to basic macromolecules is equal at pH 7.4, and that
within an electrostatic context, SA-vesicles and PG-vesicles
interact similarly with basic compounds at physiological pH.
It has been shown that electrostatic interactions are involved
in the binding of C1q to the surface of anionic vesicles con-
taining acidic phospholipid [6]. In the event that the negativeFig. 5. Change in zeta potential of vesicles as a function of the concentration of
basic oligomer (pentalysine). Vesicles were dispersed at 100 μg/mL in 10 mM
HEPES buffer (pH 7.4, at 37 °C, NaCl, 20 mM) containing various amount of
pentalysine. The lines have slopes of 9.3 and 7.4 mVper decade for the pentalysine
concentrations in SA-vesicles and PG-vesicles. SA-vesicles: PC/CH/SA (1:1:0.2,
molar ratio) and PG-vesicles: PC/CH/PG (1:1:0.2, molar ratio).charge on the surface of vesicles is critical for complement
activation, both the SA-vesicles and PG-vesicles should be
capable of activating the complement system to similar deg-
ree. We therefore conducted animal experiments to clarify the
issue of complement activation by the anionic electrostatic
charge of vesicles.Fig. 7. Comparison of the 50% hemolytic unit of complement (CH50) in rat
serum at 1 or 24 h after infusion of saline (control), SA-vesicles, or PG-vesicles.
CH50 value for PG-vesicles was significantly lower than that of the control
(pb0.01 at 1 h, p=0.013 at 24 h), indicating the complement consumption in
serum after activation. Equal CH50 value for SA-vesicles with the control
indicates that SA-vesicles failed to activate complement.
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Serum was collected at 1 and 24 h after the infusion of SA-
vesicles or PG-vesicles in experimental rats to determine CH50
levels. The control group received saline as a vehicle. The values
of CH50 in control rats, and SA-vesicles- and PG-vesicles-
administered rats, were 55.1±4.1 U/mL, 53.2±4.8 U/mL, and
29.3±1.6 U/mL at 1 h after infusion of sample, respectively. At
24 h, the values of CH50 in control rats, and SA-vesicles- and
PG-vesicles-administered rats, were 54.0±4.7 U/mL, 56.5±
3.3 U/mL, and 35.8±2.3 U/mL, respectively (Fig. 7). The lower
CH50 levels observed in the PG-vesicles-administered group
in comparison with the control group indicate that comple-
ment consumption occurred after activation. These findings
imply that significant complement activation is induced in rats
receiving PG-vesicles compared to the control group (pb0.01
at 1 h, p=0.013 at 24 h). Complement consumption was not
observed in rats administered SA-vesicles.
Since the negative charge and electrostatic interactivity of
SA-vesicles were the same as in PG-vesicles (Figs. 2–6), the
data obtained from the animal experiments indicates that
the negative charge on the anionic vesicle is not a critical
factor underlying the activation of complement. The first step
in the activation of the classical complement pathway involves
the binding of an activator to C1q, resulting in the activation
of serine proteases C1r and C1s. It has been suggested that
the negative charge of an activator such as PG-vesicles is
involved in some way with the binding of the activator to C1q
[1–8]. Assuming that the electrostatic interaction is non-
specific, SA-vesicles should interact with C1q electrostatically.
Since the action of complement proteases, which follows the
binding of the activator to the C1q, is known to be highly
specific [32,33], it seems likely that complement activation on
anionic surface is limited to an activation step rather than a
binding step. Such specific activation of complement by the
anionic vesicles in the present study may be involved in the
physiological regulation of complement activation on anionic
biomembranes.
4. Conclusions
The carboxylic acid of SA and phosphoric acid of PG have
equal capacity as anionic components of vesicles at neutral pH.
The results presented in this investigation demonstrated that the
negative electrostatic charge of anionic vesicles is not a critical
factor in the activation of complement. Rather, the induction of
complement activation by anionic vesicles is dependent on the
structure of acidic lipids. This finding may facilitate develop-
ment and various biological applications of anionic vesicles.
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